Published in Evid Based Complement Alternat Med on September 01, 2013
Treatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington's disease. Drug Des Devel Ther (2015) 0.83
Ligustrazinyl amides: a novel class of ligustrazine-phenolic acid derivatives with neuroprotective effects. Chem Cent J (2015) 0.79
Establishment of a comprehensive list of candidate antiaging medicinal herb used in korean medicine by text mining of the classical korean medical literature, "dongeuibogam," and preliminary evaluation of the antiaging effects of these herbs. Evid Based Complement Alternat Med (2015) 0.76
Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease models. Int J Nanomedicine (2015) 0.76
Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways. Redox Biol (2016) 0.75
Neuroprotective Effects of Jitai Tablet, a Traditional Chinese Medicine, on the MPTP-Induced Acute Model of Parkinson's Disease: Involvement of the Dopamine System. Evid Based Complement Alternat Med (2014) 0.75
Neuroprotective Effects of the Herbal Formula B401 in Both Cell and Mouse Models of Alzheimer's Disease. Evid Based Complement Alternat Med (2016) 0.75
Caesalpinia Crista Linn. Induces Protection against DNA and Membrane Damage. Pharmacogn Mag (2017) 0.75
Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease. CNS Drugs (2017) 0.75
Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev (2010) 4.04
Biological effects of resveratrol. Life Sci (2000) 3.23
Novel pharmacological targets for the treatment of Parkinson's disease. Nat Rev Drug Discov (2006) 2.23
Plant-derived compounds in clinical trials. Drug Discov Today (2007) 1.98
Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol (2012) 1.72
Biological effects of resveratrol. Antioxid Redox Signal (2001) 1.46
Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry (2004) 1.44
Neurotoxic in vivo models of Parkinson's disease recent advances. Prog Brain Res (2010) 1.41
Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. Neurosignals (2011) 1.30
Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS One (2011) 1.28
Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation. Neurochem Int (2010) 1.28
Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res (2004) 1.23
Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats. J Biomed Sci (2009) 1.20
Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists. Br J Pharmacol (2005) 1.20
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol (2008) 1.17
Protective effects of resveratrol and quercetin against MPP+ -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol (2009) 1.12
Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor. Br J Pharmacol (2006) 1.08
The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. Prog Brain Res (2010) 1.06
Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res (2010) 1.05
Neuroprotective effects of the antiparkinson drug Mucuna pruriens. Phytother Res (2004) 1.05
Neuroprotective potential of phytochemicals. Pharmacogn Rev (2012) 1.05
Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem (2008) 1.03
Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacol Biochem Behav (2009) 1.02
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model. BMC Neurosci (2010) 1.01
Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation. Chembiochem (2011) 1.01
Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway. Br J Pharmacol (2009) 1.00
Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a systematic review. Mov Disord (2006) 1.00
Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide. Brain Res Rev (2007) 1.00
Effects of tenuifolin extracted from radix polygalae on learning and memory: a behavioral and biochemical study on aged and amnesic mice. Phytomedicine (2008) 0.99
Paralysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise. Mov Disord (1990) 0.99
Traditional and complementary therapies in Parkinson's disease. Adv Neurol (1999) 0.99
Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Eur J Pharmacol (2009) 0.99
Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models. J Ethnopharmacol (2010) 0.98
Puerarin and conjugate bases as radical scavengers and antioxidants: molecular mechanism and synergism with beta-carotene. J Agric Food Chem (2007) 0.98
Paeoniflorin, a potent natural compound, protects PC12 cells from MPP+ and acidic damage via autophagic pathway. J Ethnopharmacol (2010) 0.97
Traditional Chinese medicine for Parkinson's disease: a review of Chinese literature. Behav Pharmacol (2006) 0.97
Astragaloside IV prevents MPP⁺-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production. Mol Cell Biochem (2012) 0.97
Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation. J Ethnopharmacol (2005) 0.97
Curcumin and curcumin-like molecules: from spice to drugs. Curr Med Chem (2014) 0.97
Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Cell Mol Neurobiol (2011) 0.96
Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models? J Ethnopharmacol (2011) 0.95
Recent advances in herbal medicines treating Parkinson's disease. Fitoterapia (2012) 0.95
Protective effects of xyloketal B against MPP+-induced neurotoxicity in Caenorhabditis elegans and PC12 cells. Brain Res (2010) 0.95
Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience (2007) 0.94
Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model. Evid Based Complement Alternat Med (2013) 0.94
Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia. CNS Neurosci Ther (2012) 0.93
Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo. J Ethnopharmacol (2010) 0.93
Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease. Brain Res (2010) 0.93
Asiaticoside: attenuation of neurotoxicity induced by MPTP in a rat model of Parkinsonism via maintaining redox balance and up-regulating the ratio of Bcl-2/Bax. Pharmacol Biochem Behav (2011) 0.93
Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP(+)-elicited apoptosis. Neurosci Res (2008) 0.92
A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism Relat Disord (2010) 0.92
Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy. J Neuroimmune Pharmacol (2013) 0.92
S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice. J Nutr Biochem (2010) 0.90
Protective effect of extract of Acanthopanax senticosus Harms on dopaminergic neurons in Parkinson's disease mice. Phytomedicine (2012) 0.89
Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells. J Neuroinflammation (2013) 0.89
Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease. Eur J Pharmacol (2007) 0.89
Involvement of activation of PI3K/Akt pathway in the protective effects of puerarin against MPP+-induced human neuroblastoma SH-SY5Y cell death. Neurochem Int (2012) 0.88
Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in parkinsonian rats. J Neurol Sci (2011) 0.88
Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci Lett (2008) 0.88
Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo. Acta Pharmacol Sin (2010) 0.88
Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neurosci Lett (2008) 0.87
Tetramethylpyrazine inhibits production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through blockade of MAPK and PI3K/Akt signaling pathways, and suppression of intracellular reactive oxygen species. J Ethnopharmacol (2010) 0.87
Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells. J Ethnopharmacol (2011) 0.87
Echinacoside prevents the striatal extracellular levels of monoamine neurotransmitters from diminution in 6-hydroxydopamine lesion rats. J Ethnopharmacol (2007) 0.86
Ethanol extract of Scutellaria baicalensis Georgi prevents oxidative damage and neuroinflammation and memorial impairments in artificial senescense mice. J Biomed Sci (2011) 0.86
Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake. Neuropharmacology (2009) 0.85
Xanthone O-glycosides from Polygala tenuifolia. Phytochemistry (2002) 0.85
Rg1 protects iron-induced neurotoxicity through antioxidant and iron regulatory proteins in 6-OHDA-treated MES23.5 cells. J Cell Biochem (2010) 0.85
Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochem Int (2008) 0.85
Neuroprotective effects of umbelliferone and esculetin in a mouse model of Parkinson's disease. J Neurosci Res (2012) 0.85
Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice. Brain Res (2010) 0.85
Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism. J Neurochem (2010) 0.84
ASICs mediate the modulatory effect by paeoniflorin on α-synuclein autophagic degradation. Brain Res (2011) 0.84
[Protective effects of Cistanche total glycosides on dopaminergic neuron in substantia nigra of model mice of Parkinson's disease]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2008) 0.84
Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells. J Ethnopharmacol (2010) 0.84
Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. Planta Med (2010) 0.83
Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells. Neurosci Lett (2010) 0.83
Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studies. CNS Neurol Disord Drug Targets (2013) 0.83
Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Pharmacol Biochem Behav (2011) 0.83
Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo. Neurochem Res (2012) 0.83
Four new phenones from the cortexes of Polygala tenuifolia. Chem Pharm Bull (Tokyo) (2005) 0.83
Protocatechuic acid suppresses MPP+ -induced mitochondrial dysfunction and apoptotic cell death in PC12 cells. Food Chem Toxicol (2006) 0.83
Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. Neurochem Int (2009) 0.83
Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria. Eur J Pharmacol (2011) 0.83
Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo. Biol Pharm Bull (2012) 0.82
Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease through suppressing mitochondria dysfunction. Transl Neurodegener (2012) 0.82
Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells. Molecules (2011) 0.82
Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation. Int J Oncol (2012) 0.82
Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. J Neuroimmune Pharmacol (2012) 0.81
Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free Radic Biol Med (2012) 0.81
Tenuigenin protects dopaminergic neurons from inflammation-mediated damage induced by the lipopolysaccharide. CNS Neurosci Ther (2012) 0.81
Assessment of the treatment effect of baicalein on a model of Parkinsonian tremor and elucidation of the mechanism. Life Sci (2012) 0.81
Behavioral recovery following sub-chronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson's disease. J Ethnopharmacol (2007) 0.81
Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury. Neurosci Lett (2011) 0.80
Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Brain Res (2011) 0.80
Naphthazarin has a protective effect on the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model. J Neurosci Res (2012) 0.80
Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism. Neurodegener Dis (2011) 0.80
Panaxatriol saponins extracted from Panax notoginseng induces thioredoxin-1 and prevents 1-methyl-4-phenylpyridinium ion-induced neurotoxicity. J Ethnopharmacol (2009) 0.80
Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. J Nutr Biochem (2009) 0.79
Magnolol Protects against MPTP/MPP(+)-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson's Disease. Parkinsons Dis (2012) 0.79
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci (2002) 4.38
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci U S A (2003) 2.74
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem (2004) 2.43
Crystal structure of a eukaryotic phosphate transporter. Nature (2013) 1.60
Clustering approaches to identifying gene expression patterns from DNA microarray data. Mol Cells (2008) 1.53
Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.41
A phosphate transporter from the root endophytic fungus Piriformospora indica plays a role in phosphate transport to the host plant. J Biol Chem (2010) 1.38
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci (2006) 1.34
Pathogenic role of glial cells in Parkinson's disease. Mov Disord (2003) 1.25
Normalization of microarray data: single-labeled and dual-labeled arrays. Mol Cells (2006) 1.14
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Mediators Inflamm (2013) 1.12
Computational approaches to gene prediction. J Microbiol (2006) 1.06
Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes. Acta Diabetol (2008) 1.05
Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Nat Prod Rep (2014) 1.04
The role of bioactive compounds on the promotion of neurite outgrowth. Molecules (2012) 1.00
Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease. Mediators Inflamm (2012) 1.00
The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism. Int J Mol Sci (2012) 0.97
Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. Diabetes Res Clin Pract (2011) 0.97
Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem (2005) 0.96
Anti-inflammatory and anti-allergic effects of Agrimonia pilosa Ledeb extract on murine cell lines and OVA-induced airway inflammation. J Ethnopharmacol (2012) 0.94
Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model. Evid Based Complement Alternat Med (2013) 0.94
Neonatal prolapsed patent vitellointestinal duct. BMJ Case Rep (2013) 0.92
Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease. Free Radic Biol Med (2009) 0.91
Massive lower gastrointestinal haemorrhage in a teenager caused by Campylobacter enteritis. BMJ Case Rep (2013) 0.91
Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κB and p38 MAPK signaling pathways. PLoS One (2013) 0.91
Anaesthetic management of a child presenting with intrapericardial teratoma compressing the airway and the heart. Ann Card Anaesth (2009) 0.90
Acute renal failure in pregnancy in a developing country: twenty years of experience. Ren Fail (2006) 0.90
Promising therapeutics with natural bioactive compounds for improving learning and memory--a review of randomized trials. Molecules (2012) 0.90
Prescription practices and availability of artemisinin monotherapy in India: where do we stand? Malar J (2011) 0.89
Oral cancer: risk factors and molecular pathogenesis. J Maxillofac Oral Surg (2011) 0.89
Identification of two novel primate-specific genes in DSCR. DNA Res (2002) 0.88
Retrospective study of chikungunya outbreak in urban areas of India. Indian J Med Res (2012) 0.88
Modulation of LPS-stimulated neuroinflammation in BV-2 microglia by Gastrodia elata: 4-hydroxybenzyl alcohol is the bioactive candidate. J Ethnopharmacol (2011) 0.88
Effects of astaxanthin on the production of NO and the expression of COX-2 and iNOS in LPS-stimulated BV2 microglial cells. J Microbiol Biotechnol (2008) 0.87
Primary group A streptococcal septic shock syndrome simulating perforated appendicitis in a previously healthy girl. BMJ Case Rep (2013) 0.86
Induction of microglial apoptosis by corticotropin-releasing hormone. J Neurochem (2006) 0.86
Contribution of TLR2 to the initiation of ganglioside-triggered inflammatory signaling. Mol Cells (2008) 0.86
Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death. CNS Neurol Disord Drug Targets (2012) 0.85
Cognitive enhancing effects of alpha asarone in amnesic mice by influencing cholinergic and antioxidant defense mechanisms. Biosci Biotechnol Biochem (2012) 0.85
Dual functionality of myeloperoxidase in rotenone-exposed brain-resident immune cells. Am J Pathol (2011) 0.85
Protective effect of Chrysanthemum indicum Linne against 1-methyl-4-phenylpridinium ion and lipopolysaccharide-induced cytotoxicity in cellular model of Parkinson's disease. Food Chem Toxicol (2011) 0.84
Trilogy of foregut atresia without genetic abnormality: exception to the Martinez-Frias syndrome. BMJ Case Rep (2014) 0.84
Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studies. CNS Neurol Disord Drug Targets (2013) 0.83
Inflexin attenuates proinflammatory responses and nuclear factor-kappaB activation in LPS-treated microglia. Eur J Pharmacol (2010) 0.83
Glial cell response: A pathogenic factor in Parkinson's disease. J Neurovirol (2002) 0.83
Effect of selenium on connexin expression, angiogenesis, and antioxidant status in diabetic wound healing. Biol Trace Elem Res (2011) 0.82
Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells. Molecules (2011) 0.82
Piriformospora indica enhances plant growth by transferring phosphate. Plant Signal Behav (2011) 0.82
Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease. Molecules (2012) 0.82
Genome-wide examination of chromosomal aberrations in neuroblastoma SH-SY5Y cells by array-based comparative genomic hybridization. Mol Cells (2007) 0.82
Osteonectin-expressing cells in human stomach cancer and their possible clinical significance. Cancer Lett (2002) 0.81
Neonatal Currarino's syndrome presenting as intestinal obstruction. BMJ Case Rep (2013) 0.81
Laparoscopic reduction of ileoileal intussusception in Henoch-Schonlein purpura. BMJ Case Rep (2013) 0.81
Antidiabetic, renal/hepatic/pancreas/cardiac protective and antioxidant potential of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on streptozotocin induced diabetic rats. BMC Complement Altern Med (2014) 0.81
Chrysanthemum morifolium Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. J Ethnopharmacol (2009) 0.81
Free radical and nitric oxide toxicity in Parkinson's disease. Adv Neurol (2003) 0.81
Anti-neuroinflammatory activity of Kamebakaurin from Isodon japonicus via inhibition of c-Jun NH₂-terminal kinase and p38 mitogen-activated protein kinase pathway in activated microglial cells. J Pharmacol Sci (2011) 0.81
Appearance of osteonectin-expressing fibroblastic cells in early rat stomach carcinogenesis and stomach tumors induced with N-methyl-N'-nitro-N-nitrosoguanidine. Jpn J Cancer Res (2002) 0.80
Role of pilus proteins in adherence and invasion of Streptococcus agalactiae to the lung and cervical epithelial cells. J Biol Chem (2012) 0.80
Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease. Int J Mol Sci (2012) 0.80
Characterization of active and inactive states of CB1 receptor and the differential binding state modulation by cannabinoid agonists, antagonists and inverse agonists. Neuropharmacology (2010) 0.80
Traditional Korean East Asian medicines and herbal formulations for cognitive impairment. Molecules (2013) 0.79
Anti-neuroinflammatory activity of a novel cannabinoid derivative by inhibiting the NF-κB signaling pathway in lipopolysaccharide-induced BV-2 microglial cells. J Pharmacol Sci (2013) 0.79
Major constituents and antimicrobial activity of Korean herb Acorus calamus. Nat Prod Res (2011) 0.78
The microcephaly gene aspm is involved in brain development in zebrafish. Biochem Biophys Res Commun (2011) 0.78
Resveratrol confers protection against rotenone-induced neurotoxicity by modulating myeloperoxidase levels in glial cells. PLoS One (2013) 0.78
Pain in the ear resulting from misplaced subclavian dialysis catheter into ipsilateral internal jugular vein. Anesth Analg (2002) 0.78
Purification of a novel nitric oxide inhibitory peptide derived from enzymatic hydrolysates of Mytilus coruscus. Fish Shellfish Immunol (2013) 0.78
Purification and characterization of a nitric oxide inhibitory peptide from Ruditapes philippinarum. Food Chem Toxicol (2012) 0.77
A computational approach to the inference of sphingolipid pathways from the genome of Aspergillus fumigatus. Curr Genet (2005) 0.77
Simultaneous measurement of serotonin, dopamine and their metabolites in mouse brain extracts by high-performance liquid chromatography with mass spectrometry following derivatization with ethyl chloroformate. Biol Pharm Bull (2012) 0.76
Molecular effects of activated BV-2 microglia by mitochondrial toxin 1-methyl-4-phenylpyridinium. Neurotoxicology (2012) 0.76
MyD88-dependent Toll-like receptor signaling is required for murine macrophages response to IS2. Int Immunopharmacol (2011) 0.76
Discovery of benzo[d]imidazo[5,1-b]thiazole as a new class of phosphodiesterase 10A inhibitors. Bioorg Med Chem Lett (2013) 0.75
Primary ileoileal intussusception without a lead point simulating appendicular mass in a 4-year-old girl. BMJ Case Rep (2014) 0.75
Determinants of intravascular resistance in Indian diabetic nephropathy patients: a hospital-based study. Int J Vasc Med (2011) 0.75
A novel synthetic compound PHID (8-Phenyl-6a, 7, 8, 9, 9a, 10-hexahydro-6H-isoindolo [5, 6-g] quinoxaline-7, 9-dione) protects SH-SY5Y cells against MPP(+)-induced cytotoxicity through inhibition of reactive oxygen species generation and JNK signaling. Eur J Pharmacol (2010) 0.75
Paediatric recurrent herpetic whitlow. BMJ Case Rep (2013) 0.75
Pneumoperitoneum: a rare air leak in an infant with bronchiolitis and high-frequency oscillatory ventilation. BMJ Case Rep (2013) 0.75
Tunable Magnetism and Transport Properties in Nitride MXenes. ACS Nano (2017) 0.75
Rational Design of 2-Dimensional Metallic and Semiconducting Spintronic Materials Based on Ordered Double-Transition-Metal MXenes. J Phys Chem Lett (2016) 0.75
Covert bacteriuria in nephrotic syndrome. Indian J Pathol Microbiol (2002) 0.75
Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease. J Ethnopharmacol (2012) 0.75
Epinephrine induced digital ischemia after accidental injection from an auto injector device. Indian Pediatr (2013) 0.75
MMHD [(S,E)-2-methyl-1-(2-methylthiazol-4-yl) hexa-1,5-dien-ol], a novel synthetic compound derived from epothilone, suppresses nuclear factor-kappaB-mediated cytokine expression in lipopolysaccharide-stimulated BV-2 microglia. J Pharmacol Sci (2010) 0.75
Effect of Taurine on Viability and Proliferation of Murine Melanoma B16F10 Cells. Adv Exp Med Biol (2015) 0.75